UPB Earnings & Financial Statements
Upstream Bio, Inc.
$3.31
-$0.11(-3.22%)
43
Overall
60
Value
27
Tech
42
Quality
Market Cap
$187.32M
Volume
760.24K
52W Range
$4.37 - $33.68
Target Price
$33.67
UPB earnings and financial statements: Upstream Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
UPB Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $2.85M | $2.37M | $2.38M |
| Cost of revenue | - | $6.58M | - |
| Operating income | -$160.36M | -$77.76M | -$40.11M |
| EBITDA | -$143.25M | -$62.72M | -$21.74M |
| Net income | -$143.44M | -$62.81M | -$20.54M |
| EPS (diluted) | $-2.66 | $-5.58 | $-12.95 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $353.77M | $481.72M | $117.20M |
| Total liabilities | $14.00M | $11.87M | $9.39M |
| Shareholders’ equity | $339.77M | $469.85M | $107.81M |
| Cash and equivalents | $101.58M | $325.89M | $25.83M |
| Long-term debt | $549.0K | $1.13M | - |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | -$133.28M | -$59.17M | -$38.24M |
| Capital expenditure | -$165.0K | -$511.0K | - |
| Free cash flow | -$133.44M | -$59.68M | -$38.38M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UPB | $3.31 | -3.2% | 760.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |